Keyphrases
Randomized Placebo-controlled Trial
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Depression Recurrence
100%
Sertraline
100%
Depression Prevention
100%
Major Depressive Disorder
55%
Hemoglobin Level
55%
Glycated Hemoglobin
55%
Placebo
44%
Patients with Diabetes
33%
Maintenance Therapy
22%
Treatment Group
11%
Confidence Interval
11%
Hazard Ratio
11%
Randomized Double-blind
11%
Placebo-controlled
11%
DSM-IV
11%
Type 2 Diabetes Mellitus (T2DM)
11%
Treatment Phase
11%
University of Washington
11%
Clinical Prognosis
11%
St. Louis
11%
Treatment Trials
11%
Elapsed Time
11%
Mean Dose
11%
Prevent Recurrence
11%
Number of Days
11%
Glycemic Control
11%
Patients with Diabetes Mellitus
11%
Outpatient Clinic
11%
Maintenance Treatment
11%
Seattle
11%
Sustained Remission
11%
Free Interval
11%
Level Reduction
11%
Open Treatment
11%
Arizona
11%
Recurrent Problems
11%
Tucson
11%
Sertraline Hydrochloride
11%
Nursing and Health Professions
Diabetes Mellitus
100%
Recurrent Disease
100%
Placebo
100%
Sertraline
100%
Hemoglobin Blood Level
50%
Major Depression
50%
Glycosylated Hemoglobin
50%
Patient with Diabetes
40%
Maintenance Therapy
30%
Remission
10%
Confidence Interval
10%
Non Insulin Dependent Diabetes Mellitus
10%
Hazard Ratio
10%
Randomization
10%
DSM-IV
10%
Outpatient Department
10%
Treatment Group
10%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Recurrent Disease
100%
Diabetes Mellitus
100%
Sertraline
100%
Major Depression
50%
Glycosylated Hemoglobin
50%
Remission
10%
DSM-IV
10%
Non Insulin Dependent Diabetes Mellitus
10%
Treatment Group
10%
Neuroscience
Placebo
100%
Diabetes Mellitus
100%
Sertraline
100%
Major Depressive Disorder
50%
Glycosylated Hemoglobin
50%